Search

everythinglearnresearchcommunity

for

Search:↓

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

IL-18 signaling helps mature Tregs move into the thymus.

New vaccine technologies are improving global health by making vaccines more effective and long-lasting.

Mogamulizumab can cause hair loss and skin rashes.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Two patients got Cushing's syndrome after treatment with Triamcinolone Acetonide for mouth fibrosis, but recovered after stopping the treatment.

Using a strong allergy medicine too often on the scalp can cause swelling and inflammation.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Post-Exposure Syndromes are persistent conditions caused by past exposures, needing unique interventions.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Travel history and tick-borne diseases should be considered in unexplained fevers for timely diagnosis and treatment.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.